Inclusion Criteria:  newly diagnosed histopathologically proven stage I and II lung cancer.  Exclusion Criteria:  : patients who have pulmonary secondaries or metastasis (usually multiple and widespread tumors), and who received treatment for lung cancer or those suffering from other malignancies elsewhere were excluded from the current study.